Share

Shanghai ZJ Bio-Tech Co., Ltd

CN¥ 27.17

Last Updated 29.08.2025

Issuer Rating

3/7

Performance

Average

Risk

High

Recommendation

Sell

Market Cap

CN¥ 703.68M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks

CN¥ 27.17

Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable price performance

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular genetic diagnostic reagents, and instruments and equipment in China. The company was founded in 2005 and is based in Shanghai, China.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is overpriced on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks